1. Home
  2. REGN vs EA Comparison

REGN vs EA Comparison

Compare REGN & EA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$745.77

Market Cap

79.3B

Sector

Health Care

ML Signal

HOLD

Logo Electronic Arts Inc.

EA

Electronic Arts Inc.

HOLD

Current Price

$204.28

Market Cap

51.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
REGN
EA
Founded
1988
1982
Country
United States
United States
Employees
15207
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
79.3B
51.1B
IPO Year
1991
N/A

Fundamental Metrics

Financial Performance
Metric
REGN
EA
Price
$745.77
$204.28
Analyst Decision
Buy
Buy
Analyst Count
24
22
Target Price
$799.33
$185.81
AVG Volume (30 Days)
818.5K
1.6M
Earning Date
01-30-2026
02-03-2026
Dividend Yield
0.47%
0.37%
EPS Growth
2.88
N/A
EPS
41.59
3.45
Revenue
$14,247,800,000.00
$7,288,000,000.00
Revenue This Year
$2.08
$10.73
Revenue Next Year
$6.82
$3.61
P/E Ratio
$18.13
$59.17
Revenue Growth
2.89
N/A
52 Week Low
$476.49
$115.21
52 Week High
$821.11
$204.89

Technical Indicators

Market Signals
Indicator
REGN
EA
Relative Strength Index (RSI) 45.12 59.30
Support Level $743.94 $204.03
Resistance Level $766.64 $204.60
Average True Range (ATR) 19.11 0.34
MACD -6.71 -0.15
Stochastic Oscillator 4.91 29.83

Price Performance

Historical Comparison
REGN
EA

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

About EA Electronic Arts Inc.

Electronic Arts is one of the largest global developers and publishers of video games. Its most important franchises are the Madden NFL and FC soccer games, which it releases annually. In 2024, it also relaunched its American college football game. Other major franchises include Apex Legends, Battlefield, and The Sims. Typically, about three quarters of the firm's sales are from in-game spending, with the remainder coming from initial game sales.

Share on Social Networks: